title: Chronic hepatitis B: whom to treat and for how long? Propositions, challenges, and future directions.
authors.affiliation: Department of Internal Medicine,Yonsei University College of Medicine,250 Sungsanno, Seodaemun-gu, Seoul 120-752, South Korea. ahnsh@yuhs.ac
authors.forename: Sang Hoon
authors.initials: SH
authors.lastname: Ahn
authors.forename: Henry L Y
authors.initials: HL
authors.lastname: Chan
authors.forename: Pei-Jer
authors.initials: PJ
authors.lastname: Chen
authors.forename: Jun
authors.initials: J
authors.lastname: Cheng
authors.forename: Mahesh K
authors.initials: MK
authors.lastname: Goenka
authors.forename: Jinlin
authors.initials: J
authors.lastname: Hou
authors.forename: Seng Gee
authors.initials: SG
authors.lastname: Lim
authors.forename: Masao
authors.initials: M
authors.lastname: Omata
authors.forename: Teerha
authors.initials: T
authors.lastname: Piratvisuth
authors.forename: Qing
authors.initials: Q
authors.lastname: Xie
authors.forename: Hyung Joon
authors.initials: HJ
authors.lastname: Yim
authors.forename: Man-Fung
authors.initials: MF
authors.lastname: Yuen
keywords: ALT; Chronic hepatitis B (CHB); HBV DNA; Hepatitis B virus (HBV); Interferon alfa; Nucleoside/nucleotide analog